Depression Screening in Diabetes Care to Improve Outcomes: Are We Meeting the Challenge?

Mykell Barnacle, Mark A. Strand, Amy Werremeyer, Brody Maack, Natasha Petry

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: Evidence-based guidelines recommend regular depression screening among individuals with type 2 diabetes mellitus (T2DM). The purpose of this study is to examine depression screening patterns among a primary care population with T2DM, through use of the Patient Health Questionnaire-9 (PHQ-9). Methods: In total, 1817 patients with T2DM were analyzed through a retrospective observational study at 2 sites, a regional health center and a federally qualified health center (FQHC). The T2DM sample was divided into those with and without a major depressive disorder (MDD) diagnosis. Depression screening rates and depression severity were assessed through the PHQ-9. Results: Both sites had higher rates of PHQ-9 screening among individuals with a history of MDD (64.82%) vs those without MDD (11.39%). Individuals from the FQHC without a history of depression had a higher mean PHQ-9 score (10.11) than those with a previous MDD diagnosis at both RHS and FQHC (7.16 and 9.85, respectively). Conclusions: Depression screening rates among individuals with diabetes and no history of MDD were remarkably low. Patients with diabetes but no MDD diagnosis who sought health care at a FQHC clinic had more depressive symptoms than those with a history of MDD at both sites. Individuals with diabetes and who have a MDD diagnosis are much more likely to receive regular depression screening than those without MDD, which leaves a substantial proportion of patients with undetected depression. Depression screening must be enhanced for all individuals with diabetes, particularly for low-income individuals and those without a previous diagnosis of MDD.

Original languageEnglish (US)
Pages (from-to)646-651
Number of pages6
JournalDiabetes Educator
Volume42
Issue number5
DOIs
StatePublished - Oct 1 2016

Fingerprint

Major Depressive Disorder
Depression
Health
Type 2 Diabetes Mellitus
Observational Studies
Primary Health Care
Retrospective Studies
Guidelines
Delivery of Health Care
Surveys and Questionnaires

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Health Professions (miscellaneous)

Cite this

Depression Screening in Diabetes Care to Improve Outcomes : Are We Meeting the Challenge? / Barnacle, Mykell; Strand, Mark A.; Werremeyer, Amy; Maack, Brody; Petry, Natasha.

In: Diabetes Educator, Vol. 42, No. 5, 01.10.2016, p. 646-651.

Research output: Contribution to journalArticle

Barnacle, Mykell ; Strand, Mark A. ; Werremeyer, Amy ; Maack, Brody ; Petry, Natasha. / Depression Screening in Diabetes Care to Improve Outcomes : Are We Meeting the Challenge?. In: Diabetes Educator. 2016 ; Vol. 42, No. 5. pp. 646-651.
@article{a98cbf895a02416d916f7661843b99c7,
title = "Depression Screening in Diabetes Care to Improve Outcomes: Are We Meeting the Challenge?",
abstract = "Purpose: Evidence-based guidelines recommend regular depression screening among individuals with type 2 diabetes mellitus (T2DM). The purpose of this study is to examine depression screening patterns among a primary care population with T2DM, through use of the Patient Health Questionnaire-9 (PHQ-9). Methods: In total, 1817 patients with T2DM were analyzed through a retrospective observational study at 2 sites, a regional health center and a federally qualified health center (FQHC). The T2DM sample was divided into those with and without a major depressive disorder (MDD) diagnosis. Depression screening rates and depression severity were assessed through the PHQ-9. Results: Both sites had higher rates of PHQ-9 screening among individuals with a history of MDD (64.82{\%}) vs those without MDD (11.39{\%}). Individuals from the FQHC without a history of depression had a higher mean PHQ-9 score (10.11) than those with a previous MDD diagnosis at both RHS and FQHC (7.16 and 9.85, respectively). Conclusions: Depression screening rates among individuals with diabetes and no history of MDD were remarkably low. Patients with diabetes but no MDD diagnosis who sought health care at a FQHC clinic had more depressive symptoms than those with a history of MDD at both sites. Individuals with diabetes and who have a MDD diagnosis are much more likely to receive regular depression screening than those without MDD, which leaves a substantial proportion of patients with undetected depression. Depression screening must be enhanced for all individuals with diabetes, particularly for low-income individuals and those without a previous diagnosis of MDD.",
author = "Mykell Barnacle and Strand, {Mark A.} and Amy Werremeyer and Brody Maack and Natasha Petry",
year = "2016",
month = "10",
day = "1",
doi = "10.1177/0145721716662917",
language = "English (US)",
volume = "42",
pages = "646--651",
journal = "Diabetes Educator",
issn = "0145-7217",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Depression Screening in Diabetes Care to Improve Outcomes

T2 - Are We Meeting the Challenge?

AU - Barnacle, Mykell

AU - Strand, Mark A.

AU - Werremeyer, Amy

AU - Maack, Brody

AU - Petry, Natasha

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Purpose: Evidence-based guidelines recommend regular depression screening among individuals with type 2 diabetes mellitus (T2DM). The purpose of this study is to examine depression screening patterns among a primary care population with T2DM, through use of the Patient Health Questionnaire-9 (PHQ-9). Methods: In total, 1817 patients with T2DM were analyzed through a retrospective observational study at 2 sites, a regional health center and a federally qualified health center (FQHC). The T2DM sample was divided into those with and without a major depressive disorder (MDD) diagnosis. Depression screening rates and depression severity were assessed through the PHQ-9. Results: Both sites had higher rates of PHQ-9 screening among individuals with a history of MDD (64.82%) vs those without MDD (11.39%). Individuals from the FQHC without a history of depression had a higher mean PHQ-9 score (10.11) than those with a previous MDD diagnosis at both RHS and FQHC (7.16 and 9.85, respectively). Conclusions: Depression screening rates among individuals with diabetes and no history of MDD were remarkably low. Patients with diabetes but no MDD diagnosis who sought health care at a FQHC clinic had more depressive symptoms than those with a history of MDD at both sites. Individuals with diabetes and who have a MDD diagnosis are much more likely to receive regular depression screening than those without MDD, which leaves a substantial proportion of patients with undetected depression. Depression screening must be enhanced for all individuals with diabetes, particularly for low-income individuals and those without a previous diagnosis of MDD.

AB - Purpose: Evidence-based guidelines recommend regular depression screening among individuals with type 2 diabetes mellitus (T2DM). The purpose of this study is to examine depression screening patterns among a primary care population with T2DM, through use of the Patient Health Questionnaire-9 (PHQ-9). Methods: In total, 1817 patients with T2DM were analyzed through a retrospective observational study at 2 sites, a regional health center and a federally qualified health center (FQHC). The T2DM sample was divided into those with and without a major depressive disorder (MDD) diagnosis. Depression screening rates and depression severity were assessed through the PHQ-9. Results: Both sites had higher rates of PHQ-9 screening among individuals with a history of MDD (64.82%) vs those without MDD (11.39%). Individuals from the FQHC without a history of depression had a higher mean PHQ-9 score (10.11) than those with a previous MDD diagnosis at both RHS and FQHC (7.16 and 9.85, respectively). Conclusions: Depression screening rates among individuals with diabetes and no history of MDD were remarkably low. Patients with diabetes but no MDD diagnosis who sought health care at a FQHC clinic had more depressive symptoms than those with a history of MDD at both sites. Individuals with diabetes and who have a MDD diagnosis are much more likely to receive regular depression screening than those without MDD, which leaves a substantial proportion of patients with undetected depression. Depression screening must be enhanced for all individuals with diabetes, particularly for low-income individuals and those without a previous diagnosis of MDD.

UR - http://www.scopus.com/inward/record.url?scp=84988353564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988353564&partnerID=8YFLogxK

U2 - 10.1177/0145721716662917

DO - 10.1177/0145721716662917

M3 - Article

C2 - 27558266

AN - SCOPUS:84988353564

VL - 42

SP - 646

EP - 651

JO - Diabetes Educator

JF - Diabetes Educator

SN - 0145-7217

IS - 5

ER -